Instrument Inactif

Communiqués LEIE ACQUPAR

Actions

LACQ

US52539T1079

Recherche biotechnologique et médicale

Communiqués

31/03/22	Ensysce Biosciences Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results	GL
31/01/22	Ensysce Biosciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communication Program	GL
19/01/22	Ensysce Biosciences Reminds Stockholders to Vote at Upcoming Special Meeting	GL
04/01/22	Ensysce Biosciences Achieves Successful Completion of Part A of Multiple-Ascending Dose (MAD)/Bioequivalents (BE) Trial for its Next Generation Opioid, PF614	GL
15/11/21	Ensysce Biosciences Reports Third Quarter 2021 Financial Results and Recent Corporate Updates	GL
02/07/21	LEIE ACQUPAR : Ensysce Biosciences to Begin Trading its Common Stock on The Nasdaq Capital Market on July 2, 2021 (Form 8-K)	PU
01/07/21	ENSYSCE BIOSCIENCES, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
01/07/21	Leisure Acquisition : Ensysce Biosciences Announces Closing of Merger (Form 8-K)	PU
01/07/21	ENSYSCE BIOSCIENCES, INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
30/06/21	LEISURE ACQUISITION : Submission of Matters to a Vote of Security Holders (form 8-K/A)	AQ
29/06/21	LEISURE ACQUISITION CORP. : Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
17/06/21	Special Meeting Proxy Statement (Meeting Date: June 28, 2021)	PU
11/06/21	Leisure Acquisition : Material Definitive Agreement (Form 8-K)	PU
11/06/21	LEISURE ACQUISITION CORP. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities (form 8-K)	AQ
08/06/21	LEISURE ACQUISITION : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
01/06/21	Leisure Acquisition : Announces Receipt of and Plan to Appeal Nasdaq Listing Determination (Form 8-K)	PU
01/06/21	LEISURE ACQUISITION CORP. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure (form 8-K)	AQ
01/06/21	Leisure Acquisition Corp. : Announces Receipt of and Plan to Appeal Nasdaq Listing Determination	PR
14/05/21	LEISURE ACQUISITION CORP. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)	AQ
07/05/21	LEISURE ACQUISITION CORP. : Regulation FD Disclosure (form 8-K)	AQ
07/05/21	Leisure Acquisition : Covistat to present pre-clinical data at American Thoracic Society annual meeting, May 14-19, 2021	PU
29/04/21	LEISURE ACQUISITION CORP. : Regulation FD Disclosure (form 8-K)	AQ
29/04/21	Leisure Acquisition : Ensysce Biosciences Receives Investigational New Drug Allowance for its Unique PF614-MPAR™ Opioid with Overdose Protection	AQ
15/03/21	LEISURE ACQUISITION : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ
25/02/21	LEISURE ACQUISITION CORP. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	AQ